Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy

BACKGROUND: To assess correlation of pretreatment specific growth rate (SGR) value of 0.43 × 10(‐2) with overall and failure‐free survival of patients with early‐stage non‐small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT). METHODS: A retrospective chart review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah, Soha, Le, Lisa W., Bezjak, Andrea, MacRae, Robert, Hope, Andrew J., Pantarotto, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812066/
https://www.ncbi.nlm.nih.gov/pubmed/33258301
http://dx.doi.org/10.1111/1759-7714.13744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812066/
https://www.ncbi.nlm.nih.gov/pubmed/33258301
http://dx.doi.org/10.1111/1759-7714.13744

Ejemplares similares